Package 0067-2039-50
Brand: excedrin migraine
Generic: acetaminophen, aspirin (nsaid) and caffeinePackage Facts
Identity
Package NDC
0067-2039-50
Digits Only
0067203950
Product NDC
0067-2039
Description
1 BOTTLE in 1 CARTON (0067-2039-50) / 50 TABLET, FILM COATED in 1 BOTTLE
Marketing
Marketing Status
Brand
excedrin migraine
Generic
acetaminophen, aspirin (nsaid) and caffeine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7386648a-3c0a-4586-9b61-fd824edfdfc1", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["7ed841fb-a61c-4868-b4e5-4f2311a5e79c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Haleon US Holdings LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET, FILM COATED in 1 POUCH (0067-2039-02)", "package_ndc": "0067-2039-02", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-24) / 24 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-24", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-30) / 30 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-30", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-33) / 300 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-33", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-50) / 50 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-50", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-77) / 250 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-77", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-83) / 125 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-83", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-91) / 100 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-91", "marketing_start_date": "20100215"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (0067-2039-92) / 200 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "0067-2039-92", "marketing_start_date": "20100215"}], "brand_name": "EXCEDRIN MIGRAINE", "product_id": "0067-2039_7386648a-3c0a-4586-9b61-fd824edfdfc1", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "0067-2039", "generic_name": "Acetaminophen, Aspirin (NSAID) and Caffeine", "labeler_name": "Haleon US Holdings LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "EXCEDRIN", "brand_name_suffix": "MIGRAINE", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "NDA020802", "marketing_category": "NDA", "marketing_start_date": "20100215", "listing_expiration_date": "20261231"}